MTIP is the leading European growth and buyout investor focused on the healthcare software sector. We invest in profitable, high-growth, and market-leading companies that specialize in SaaS B2B models and recurring revenue streams. Our strategy is built on a strong foundation of deep sector expertise, discipline, and a commitment to supporting visionary management teams.
As active investors, we take a hands-on approach, aligning with management teams to help execute their strategic vision. By leveraging our in-depth sector expertise, we identify and unlock growth opportunities while optimizing operational performance. We invest where our industry knowledge and our wide network can add value.
Streamlining operations, sharpening strategic focus, and unlocking key growth drivers
Identifying and executing high-impact acquisitions for sustained growth
Delivering data-driven insights to guide critical strategic decisions
Supporting the development of resilient, high-performing management teams
As an impact investor, we are committed to generating sustainable value for all stakeholders. Thus, we are proud to be SFDR Article 9 compliant as of MTIP Fund II, highlighting our commitment to sustainable investments through our products. To further our impact, we have introduced the MTIP Impact Tracker, which measures our portfolio companies' contributions to addressing healthcare inequalities. Central to this effort is the AAAQ framework - focusing on Availability, Accessibility, Acceptability, and Quality - through which we work closely with portfolio companies to define KPIs and ensure measurable progress in improving healthcare outcomes.
As drive long-term value by fully understanding the strategic fundamentals of each portfolio company through deep market research and active engagement with management teams. Our hands-on approach ensures that we can leverage our expertise to unlock growth opportunities, make strategic acquisitions, and guide key decision for future value creation.
We focus primarily on Europe.
We target healthcare software companies with SaaS B2B business models and recurring revenue.
We typically pursue equity investments of around €30m.
We seek to own majority or significant minority equity stakes in the businesses we invest in.
We target healthcare software businesses that drive measurable improvements in the availability, accessibility, acceptability, and quality of healthcare.
We target healthcare software companies with €10m+ in recurring revenues that are profitable, focusing on those with an EBITDA of up to €3m.
We typically hold investments for 3 to 5 years.
TrailBlazer is optimizing MTIP’s investment decision-making process through advanced workflow automation technology, providing MTIP with a competitive advantage and a fresh approach to data-driven insights.
TrailBlazer started in 2021 with its mission to refine MTIP’s differentiated growth / buyout investment approach. The platform is built on continuously growing data sources and can be used to identify the most promising investments for successful growth and value creation while mitigating risks.
TrailBlazer improves the investment decision-making process and mitigate risk in several ways:
Deal Sourcing: MTIP combines its in-depth healthcare software knowledge with automation capabilities to automatically identify opportunities from the most relevant data sources.
Deal Screening: TrailBlazer will analyze both existing and new investment opportunities by applying MTIP's investment criteria to current company metrics, collaborating with investment professionals to identify suitable matches quickly.
Deal Execution: Before MTIP takes an investment decision, TrailBlazer helps benchmark the potential investee to peers, identifies competitors, and supports the deal team in analyzing associated risks.
Portfolio Management & Monitoring: TrailBlazer analyzes operational data and compares performance metrics of MTIP's portfolio companies, both against each other and the broader market.